INS and Insulin resistance: Furthermore, orlistat selectively reduces visceral fat and prevents the digestion of free fatty acids, which are responsible for the increase in hepatic and peripheral insulin resistance [101], and increases the secretion of two gut hormones, GLP-1 and GIP, thus improving insulin release [102].